Journals

ISN Journal editorial selections  

Kidney International®   Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis   Patients receiving hemodialysis are especially vulnerable to respiratory syncytial virus (RSV), but vaccine responses in this group are poorly understood.   In a small observational study, the RSV vaccine Arexvy produced robust antibody and cellular immune responses, although antibody levels rose more slowly than...

September 14, 2026Journals, NewsRead more...

KIR at 10: reaching wider and thinking ahead through digital outreach and AI 

      Jai Radhakrishnan (left) and Sumit Mohan  What does kidney research publishing look like in a rapidly evolving field? As Kidney International Reports® (KIR) marks its 10th anniversary, its editors discuss how the journal is expanding engagement with the global kidney community, adapting to new developments in publishing, and looking ahead to its next...

September 14, 2026Journals, NewsRead more...

Read the latest summaries from the ISN Journal portfolio

Kidney International®   Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background  C3 glomerulopathy (C3G) has a high risk of recurrence after kidney transplantation, and there is limited evidence on how best to prevent it.  This case report describes a child with severe, early-onset C3G and a complex genetic background who received pegcetacoplan before and after a living-donor kidney transplant as prophylaxis...

August 31, 2026Journals, News, ResearchRead more...

ISN Journal summaries on strategies to target the VEGF-A pathway and AKI in children with acute malnutrition

Kidney International®  Reversal of advanced diabetic kidney disease in mice achieved with a monoclonal anti-VEGFR1 antibody Diabetic kidney disease is a major cause of kidney failure, and new treatment approaches are needed. In this study, researchers tested various strategies to target the VEGF-A pathway in mouse models of diabetic kidney disease and chronic kidney disease. They found that...

July 20, 2026Journals, NewsRead more...

ISN Journal summaries on belimumab in lupus nephritis and deceased donation in Tamil Nadu

Kidney International®   Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis   Lupus nephritis is complex and difficult to treat, and clinicians need better tools to understand which patients are most likely to benefit from specific therapies.  Using data from the Phase 3 BLISS-LN study, researchers assessed how belimumab affected immune...

July 6, 2026Journals, NewsRead more...

Call for applications: Kidney International Reports® editor-in-chief  

The ISN invites applications for editor-in-chief (EIC) of Kidney International Reports®.   The EIC will shape the journal’s editorial direction and support the publication of high-quality, clinically relevant kidney research for a global audience. Applications close on July 31, 2026.   View the role, criteria, and how to apply 

June 22, 2026JournalsRead more...

ISN Journal summaries on vitamin D for minimal change disease and AKI caused by West Nile virus  

Kidney International®   A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy  This study tested whether lower-dose prednisolone combined with activated vitamin D could match standard high-dose prednisolone for remission in adults with minimal change disease while reducing steroid toxicity.   Although non-inferiority was not formally established, the lower-dose regimen...

June 22, 2026Journals, News, ResearchRead more...

ISN Journal summaries on conventional cytotoxic chemotherapy and Taiwan’s living kidney donation policy 

Kidney International®   Conventional cytotoxic chemotherapy–associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup  Conventional cytotoxic chemotherapy remains essential in cancer care, but can cause acute and chronic kidney injury.   The 34th ADQI Workgroup reviewed the epidemiology, mechanisms, risk factors, clinical manifestations, prevention, and management of nephrotoxicity linked to commonly used agents.   The resulting consensus report emphasizes clinician awareness,...

June 8, 2026Journals, News, ResearchRead more...

10 years of Kidney International Reports®: transforming how kidney science is shared 

“We are truly a global journal: We do not just select [from] one area that has resources ... authors can submit their papers from whatever region they’re from.” Jai Radhakrishnan  As Kidney International Reports® (KIR) marks its 10th anniversary, a WCN'26 Kidney Studio interview with Editor-in-Chief Jai Radhakrishnan reflects on how a bold early commitment to open access and a dedication to...

June 8, 2026Journals, News, ResearchRead more...

KICR article in focus: rare late fungal infection after kidney transplantation 

A new case report in Kidney International Case Reports™ (KICR) describes an exceptionally rare delayed dual invasive fungal infection involving mucormycosis and aspergillosis in the native kidney of a kidney transplant recipient more than 10 years after transplantation.  Macroscopic appearance of small whitish tissue (fungal ball) passed in urine  The patient presented with fever, right loin...

May 26, 2026Journals, NewsRead more...

ISN Journal summaries on electronic alerts for AKI in Wales and patient-choice dialysis policy reform in Thailand

Kidney International® A population-based,regression discontinuity analysis examined the effects of nationwide alerting for acute kidney injury on health care and patient outcomes This study assessed whether Wales’ nationwide electronic alerts for acute kidney injury (AKI) improved care or patient outcomes in real-world practice. Using a population-based regression discontinuity analysis of hospital and community data from 2016 to...

May 26, 2026Journals, NewsRead more...

ISN Journal summaries on B cell-targeting immunotherapies and eGFR slope in the cardiorenal continuum

Kidney International®   Tiny warriors, big impact: targeted immunotherapy in kidney diseases  This review examines whether emerging B cell-targeting immunotherapies, particularly chimeric antigen receptor T-cell therapy and T-cell engagers, could improve outcomes in autoimmune kidney diseases where current treatments often fail.  It summarizes early evidence, mainly from small uncontrolled studies in systemic lupus erythematosus, suggesting these approaches may achieve deeper B-cell depletion...

May 11, 2026Journals, News, ResearchRead more...

Jai Radhakrishnan appointed KI Editor-in-Chief

Jai Radhakrishnan named Editor-in-Chief of Kidney International® May 7, 2026 The International Society of Nephrology (ISN) is pleased to announce the appointment of Jai Radhakrishnan, MD, as the next Editor-in-Chief of Kidney International® (KI), the Society’s flagship journal. His term will begin on January 1, 2027, succeeding Pierre Ronco, MD, PhD. Dr. Radhakrishnan is a Professor of...

May 7, 2026Journals, NewsRead more...

First edition of KICR highlights real-world lessons in kidney care 

From unusual presentations and diagnostic dilemmas to novel treatment approaches, the first in press case reports featured in Kidney International Case Reports™ (KICR) highlight clinically relevant lessons from real-world kidney care across diverse global settings.  Explore the first edition  Among the early reports are cases that underline how rapidly evolving therapies are reshaping practice. Al Haddad...

April 27, 2026Journals, NewsRead more...

ISN Journal summaries on corticosteroid treatment in IgAN and the impact of CKD on life participation

Kidney International®   A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy  This study addressed how to better target corticosteroid treatment in IgA nephropathy, (IgAN) where benefits must be weighed against important side effects.   Using a secondary analysis of the TESTING trial, the authors developed a model to predict each patient’s likely response to...

April 27, 2026Journals, NewsRead more...

KIR: A platform for researchers worldwide, emerging voices, and progress in global kidney care 

Ten years ago, Kidney International Reports® (KIR) launched with a clear mission: to expand access to high-quality kidney research and ensure that important discoveries reach clinicians, researchers, and health systems worldwide.  Over the past decade, the journal has published studies that have shaped care and policy, fostered opportunities for early-career researchers to contribute and collaborate, and elevated voices...

April 13, 2026Journals, NewsRead more...

Explore WCN’26 late-breaking trials with NephJC and Kidney International Reports® 

NephJC has extended the conversation around WCN’26 late-breaking trials with expert commentary on selected studies presented in Yokohama, including the ASSIST trial, 24-month data from APPLAUSE-IGAN, and new analyses from the CONFIDENCE trial.  Read the commentaries  A video interview recorded onsite at WCN’26 in Yokohama features NephJC Founding Editor-in-Chief Swapnil Hiremath and Managing Editor Cristina Popa discussing selected late-breaking...

April 13, 2026Journals, News, Research, WCNRead more...

ISN Journal summaries on parathyroid hormone in CKD-related osteoporosis and kidney care fragility in Nepal 

Kidney International®   ​Uremia and parathyroid hormone have distinct effects on bone protein and gene expression  People with chronic kidney disease (CKD) remain at high risk of fractures despite treatment aimed at maintaining parathyroid hormone at acceptable levels.  This study examined the distinct effects of uremia and parathyroid hormone on bone in patients on hemodialysis and controls.  The authors...

April 13, 2026Journals, News, ResearchRead more...

ISN Journal summaries on modern challenges in infection prevention & CKD in migrants 

Kidney International®   Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors  This mini review examines infection prevention in patients receiving novel complement inhibitors, with a focus on serious infections caused by encapsulated organisms.   It outlines practical strategies, including vaccination, antibiotic prophylaxis, and patient education.   The authors stress that these therapies offer important benefits...

March 23, 2026Journals, NewsRead more...